Better Outcomes of 2nd Eye With Choroidal Neovascularization After Anti-VEGF Treatment Better Outcomes of 2nd Eye With Choroidal Neovascularization After Anti-VEGF Treatment

Visual acuity outcomes after anti-vascular endothelial growth factor (anti-VEGF) treatment for choroidal neovascularization (CNV) are better in fellow eyes of previously treated patients with neovascular age-related macular degeneration (nvAMD), according to a retrospective study.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news